SABS
SAB Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.72
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+9.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 26, 2026 | Kropotova Alexandra · officer: CHIEF MEDICAL OFFICER | F-InKind | 988 | $0.00 |
| Mar 25, 2026 | Kropotova Alexandra · officer: CHIEF MEDICAL OFFICER | F-InKind | 988 | $0.00 |
| Feb 5, 2026 | Reich Samuel J · director, officer: CEO | A-Award | 4,800,000 | $4.45 |
| Feb 5, 2026 | Bausch Christoph Lawrence · officer: CHIEF OPERATING OFFICER | A-Award | 1,800,000 | $4.45 |
| Feb 5, 2026 | Sullivan Eddie Joe · director, officer: PRESIDENT | A-Award | 3,000,000 | $4.45 |
| Feb 5, 2026 | To Lucy · officer: See Remarks | A-Award | 2,400,000 | $4.45 |
| Feb 5, 2026 | Kropotova Alexandra · officer: CHIEF MEDICAL OFFICER | A-Award | 2,400,000 | $4.45 |
| Jan 7, 2026 | ZACCARDELLI DAVID · director | A-Award | 240,000 | $3.74 |
| Jan 7, 2026 | Jain Rita · director | A-Award | 240,000 | $3.74 |
| Dec 18, 2025 | SKYLER JAY S · director | A-Award | 150,000 | $3.99 |
| Dec 18, 2025 | Polvino William James · director | A-Award | 150,000 | $3.99 |
| Dec 18, 2025 | Lucera Erick · director | A-Award | 150,000 | $3.99 |
| Dec 18, 2025 | Ellias Helen K. · director | A-Award | 150,000 | $3.99 |
| Dec 18, 2025 | Giberson Scott · director | A-Award | 150,000 | $3.99 |
| Dec 18, 2025 | Link David · director | A-Award | 150,000 | $3.99 |
| Dec 12, 2025 | Kropotova Alexandra · officer: CHIEF MEDICAL OFFICER | F-InKind | 988 | $0.00 |
| Oct 1, 2025 | Sessa Capital (Master), L.P. · director | M-Exempt | 1,740,000 | $1.75 |
| Oct 1, 2025 | Sessa Capital (Master), L.P. · director | M-Exempt | 17,400 | $1.75 |
| Oct 1, 2025 | Moin Andrew · director | M-Exempt | 17,400 | $1.75 |
| Oct 1, 2025 | Moin Andrew · director | M-Exempt | 1,740,000 | $1.75 |
| Sep 22, 2025 | Kropotova Alexandra · officer: CHIEF MEDICAL OFFICER | F-InKind | 1,977 | $0.00 |
| Aug 28, 2025 | To Lucy · officer: See Remarks | A-Award | 1,200,000 | $2.17 |
| Aug 28, 2025 | Kropotova Alexandra · officer: CHIEF MEDICAL OFFICER | A-Award | 2,400,000 | $2.17 |
| Aug 28, 2025 | Bausch Christoph Lawrence · officer: CHIEF OPERATING OFFICER | A-Award | 600,000 | $2.17 |
| Aug 28, 2025 | Sullivan Eddie Joe · director, officer: PRESIDENT | A-Award | 3,000,000 | $2.17 |
| Aug 28, 2025 | Reich Samuel J · director, officer: CEO & EXECUTIVE CHAIRMAN | A-Award | 4,800,000 | $2.17 |
| Jul 24, 2025 | Moin Andrew · director | A-Award | 228,500 | $1.75 |
| Jul 24, 2025 | Sessa Capital (Master), L.P. · director | A-Award | 228,500 | $1.75 |
| Jul 24, 2025 | Sessa Capital (Master), L.P. · director | A-Award | 114,250 | $219 |
| Jul 24, 2025 | Moin Andrew · director | A-Award | 114,250 | $219 |
Institutional positioning
13F filings over the trailing two quarters
New 36Increased 27Reduced 7Sold out 78
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VIVO CAPITAL, LLC | Unchanged | 11,420,000 | May 20, 2026 |
| CALIGAN PARTNERS LP | New Position | 7,967,207 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 6,431,743 | May 29, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 4,401,500 | May 15, 2026 |
| COMMODORE CAPITAL LP | Unchanged | 4,401,500 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 3,760,439 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 3,405,553 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,032,697 | May 15, 2026 |
| WOODLINE PARTNERS LP | Increased | 2,851,791 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,493,737 | May 15, 2026 |
| Spruce Street Capital LP | Unchanged | 2,198,502 | May 14, 2026 |
| SESSA CAPITAL IM, L.P. | Unchanged | 2,198,457 | May 15, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | New Position | 1,481,660 | May 15, 2026 |
| AMERIPRISE FINANCIAL INC | Increased | 1,476,106 | Jul 17, 2026 |
| ENSIGN PEAK ADVISORS, INC | New Position | 1,375,610 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 26, 2026